Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 21 studies | 43% ± 18% | |
endothelial cell | 19 studies | 33% ± 12% | |
oligodendrocyte | 17 studies | 49% ± 18% | |
oligodendrocyte precursor cell | 14 studies | 31% ± 13% | |
macrophage | 13 studies | 31% ± 13% | |
fibroblast | 13 studies | 34% ± 13% | |
microglial cell | 12 studies | 34% ± 12% | |
GABAergic neuron | 11 studies | 46% ± 23% | |
glutamatergic neuron | 11 studies | 54% ± 24% | |
B cell | 11 studies | 21% ± 7% | |
adipocyte | 9 studies | 54% ± 12% | |
smooth muscle cell | 9 studies | 28% ± 9% | |
pericyte | 8 studies | 28% ± 10% | |
ciliated cell | 8 studies | 30% ± 9% | |
neuron | 7 studies | 42% ± 23% | |
retinal ganglion cell | 7 studies | 59% ± 25% | |
dendritic cell | 7 studies | 22% ± 8% | |
mast cell | 7 studies | 25% ± 9% | |
interneuron | 6 studies | 51% ± 24% | |
epithelial cell | 6 studies | 42% ± 17% | |
retina horizontal cell | 6 studies | 39% ± 12% | |
retinal cone cell | 6 studies | 46% ± 14% | |
Mueller cell | 6 studies | 39% ± 8% | |
endothelial cell of lymphatic vessel | 6 studies | 28% ± 8% | |
type I pneumocyte | 6 studies | 29% ± 5% | |
type II pneumocyte | 6 studies | 29% ± 5% | |
amacrine cell | 5 studies | 40% ± 9% | |
retinal rod cell | 5 studies | 45% ± 13% | |
cardiac muscle cell | 5 studies | 60% ± 14% | |
myeloid cell | 5 studies | 25% ± 7% | |
T cell | 5 studies | 25% ± 6% | |
club cell | 5 studies | 27% ± 10% | |
basal cell | 5 studies | 37% ± 18% | |
granule cell | 4 studies | 38% ± 13% | |
retinal pigment epithelial cell | 4 studies | 42% ± 21% | |
CD4-positive, alpha-beta T cell | 4 studies | 20% ± 4% | |
CD8-positive, alpha-beta T cell | 4 studies | 18% ± 5% | |
alveolar macrophage | 4 studies | 30% ± 10% | |
natural killer cell | 4 studies | 23% ± 5% | |
plasmacytoid dendritic cell | 4 studies | 25% ± 6% | |
conventional dendritic cell | 3 studies | 27% ± 7% | |
GABAergic interneuron | 3 studies | 38% ± 8% | |
glial cell | 3 studies | 26% ± 6% | |
plasma cell | 3 studies | 29% ± 6% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 21% ± 6% | |
retinal bipolar neuron | 3 studies | 29% ± 6% | |
mononuclear phagocyte | 3 studies | 20% ± 2% | |
GABAergic amacrine cell | 3 studies | 37% ± 4% | |
OFF-bipolar cell | 3 studies | 48% ± 26% | |
ON-bipolar cell | 3 studies | 51% ± 23% | |
glycinergic amacrine cell | 3 studies | 33% ± 2% | |
myofibroblast cell | 3 studies | 29% ± 9% | |
hepatocyte | 3 studies | 56% ± 15% | |
muscle cell | 3 studies | 48% ± 20% | |
abnormal cell | 3 studies | 34% ± 14% | |
ependymal cell | 3 studies | 51% ± 20% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 23% ± 9% | |
monocyte | 3 studies | 30% ± 9% | |
respiratory goblet cell | 3 studies | 36% ± 15% | |
lymphocyte | 3 studies | 34% ± 11% | |
mesothelial cell | 3 studies | 32% ± 9% | |
mucus secreting cell | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2422.24 | 2642 / 2642 | 100% | 28.17 | 705 / 705 |
adrenal gland | 100% | 1588.74 | 258 / 258 | 100% | 20.77 | 229 / 230 |
prostate | 99% | 650.00 | 242 / 245 | 100% | 11.42 | 502 / 502 |
breast | 100% | 663.18 | 457 / 459 | 99% | 7.20 | 1109 / 1118 |
thymus | 99% | 603.85 | 645 / 653 | 100% | 9.37 | 603 / 605 |
bladder | 100% | 575.71 | 21 / 21 | 98% | 6.34 | 495 / 504 |
uterus | 98% | 479.07 | 166 / 170 | 98% | 6.42 | 452 / 459 |
liver | 96% | 536.13 | 217 / 226 | 100% | 6.62 | 405 / 406 |
kidney | 94% | 524.74 | 84 / 89 | 99% | 6.13 | 895 / 901 |
ovary | 93% | 402.35 | 167 / 180 | 100% | 9.67 | 430 / 430 |
esophagus | 94% | 496.29 | 1355 / 1445 | 97% | 4.87 | 178 / 183 |
lung | 93% | 449.31 | 535 / 578 | 98% | 5.54 | 1136 / 1155 |
intestine | 92% | 468.73 | 887 / 966 | 98% | 4.80 | 516 / 527 |
stomach | 87% | 395.59 | 314 / 359 | 98% | 4.45 | 280 / 286 |
skin | 87% | 346.32 | 1565 / 1809 | 94% | 5.04 | 443 / 472 |
pancreas | 65% | 230.59 | 214 / 328 | 100% | 5.73 | 178 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.93 | 29 / 29 |
muscle | 100% | 3423.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 533.25 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.82 | 1 / 1 |
adipose | 99% | 683.90 | 1193 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 679.95 | 1318 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 1327.01 | 825 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 4.56 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 89% | 4.92 | 71 / 80 |
peripheral blood | 19% | 69.90 | 179 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006796 | Biological process | phosphate-containing compound metabolic process |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003998 | Molecular function | acylphosphatase activity |
Gene name | ACYP2 |
Protein name | Acylphosphatase-2 (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2) Acylphosphatase (EC 3.6.1.7) Acylphosphatase 2 Acylphosphatase-2 (EC 3.6.1.7) (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2) acylphosphatase (EC 3.6.1.7) Acylphosphatase, muscle type isozyme Acylphosphatase 2 (HCG2040114, isoform CRA_a) |
Synonyms | hCG_2040114 ACYP |
Description | FUNCTION: Its physiological role is not yet clear. |
Accessions | ENST00000394666.8 ENST00000606865.1 ENST00000406041.5 U3KQ09 Q53TK7 ENST00000494922.6 U3KPX1 U3KPX8 U3KQL2 P14621 ENST00000606082.5 U3KQ94 ENST00000303536.8 F8WA34 ENST00000422521.2 E9PF46 Q4ZFV7 ENST00000607452.6 |